ITK/SYK translocation in angioimmunoblastic T-cell lymphoma.
*Department of Histopathology, Royal Marsden Hospital, London, UK †Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Ayoma D
AD
Attygalle
Andrew L
AL
Feldman
Ahmet
A
Dogan
D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics*; D001706:Biopsy; D017809:Fatal Outcome; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D047908:Intracellular Signaling Peptides and Proteins / Q000032:analysis / Q000235:genetics*; D016399:Lymphoma, T-Cell / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D008875:Middle Aged; D010641:Phenotype; D011379:Prognosis; D011505:Protein-Tyrosine Kinases / Q000032:analysis / Q000235:genetics*; D000072377:Syk Kinase; D014178:Translocation, Genetic
D014408:Biomarkers, Tumor; D047908:Intracellular Signaling Peptides and Proteins; D011505:Protein-Tyrosine Kinases; C000606896:SYK protein, human; D000072377:Syk Kinase; C080813:emt protein-tyrosine kinase